Brief: Genovis Enters Licensing And Supply Agreement With New Bioprocess Customer

Genovis AB

10/08/2022 13:02

Aug 10 (Reuters) - Genovis AB  GENOb.ST :
    * GENOVIS ENTERS LICENSING AND SUPPLY AGREEMENT WITH NEW
BIOPROCESS CUSTOMER
    * HAS SIGNED LONG-TERM LICENSING AND SUPPLY AGREEMENT WITH
US
BASED BIOTECH COMPANY FOR SUPPLY OF SMARTENZYMES TO BE USED IN
MANUFACTURING OF CLINICAL THERAPEUTIC AGENT
    * INITIAL PRECLINICAL DEVELOPMENT ACTIVITIES ARE EXPECTED TO
BE
PERFORMED DURING FIRST 12-MONTHS AND GENERATE APPROXIMATELY FOUR
MILLION SEK IN REVENUES
    * ULTIMATE GOAL IS TO GENERATE A PLATFORM OF NOVEL
THERAPEUTIC
MOLECULES TO BRING A SERIES OF NEW TREATMENTS TO PATIENTS WITH
HIGH UNMET NEEDS

Source text for Eikon:  ID:nWkr7ry3Zy 
Further company coverage:  GENOb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))